Augmentation treatment for α1 antitrypsin deficiency

Affiliations

Comment

Ronald G Crystal. Lancet. 2015.

. 2015 Jul 25;386(9991):318-20.

doi: 10.1016/S0140-6736(15)60036-8. Epub 2015 May 27.

¹ Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: geneticmedicine@med.cornell.edu.

No abstract available

Comment on

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Chapman KR, Burdon JG, Piitulainen E, Sandhaus RA, Seersholm N, Stocks JM, Stoel BC, Huang L, Yao Z, Edelman JM, McElvaney NG; RAPID Trial Study Group. Chapman KR, et al. Lancet. 2015 Jul 25;386(9991):360-8. doi: 10.1016/S0140-6736(15)60860-1. Epub 2015 May 27. Lancet. 2015. PMID: 26026936 Clinical Trial.